Preview

Rational Pharmacotherapy in Cardiology

Advanced search

EXPERT CONSENSUS DOCUMENT ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY

Full Text:

About the Author



Russian Federation


References

1. Whittemore R, Hobbins J, Engle M. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982;50:641–51.

2. Mc Faul P, Dornan J, Lamki H et al. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol 1988;95:861–7.

3. Morgan Jones A, Howitt G. Eisenmenger syndrome in pregnancy. Br Med J 1965;1:1627.

4. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: current controversies, management and perspectives. Eur Heart J 2000;21:104–5.

5. Siu SC, Sermer M, Harrison DA et al. Risk and predictors for pregnancy related complications in women with heart disease. Circulation 1997;96:2789–94.

6. Robson SC, Hunter S, Boys RJ et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989;256:H1060–5.

7. Robson SC, Dunlop W, Boys RJ et al. Cardiac output during labour. Br Med J 1987;295:1169–72.

8. Elkayam U, Gleicher N. Hemodynamics and cardiac function during normal pregnancy and the puerperium. In: Elkayam, Gleicher N, editors. Cardiac problems in pregnancy. New York: Wiley; 1998, p. 3–19.

9. Oakley C. Pulmonary hypertension in heart disease in pregnancy. London: BMJ Publishing Group, 1997, p. 97–111.

10. Oakley C. Acyanotic congenital heart disease. Heart disease in pregnancy. London: BMJ Publishing Group; 1997, p. 63–82.

11. Presbitero P, Somerville J, Stone S et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673–6.

12. Presbitero P, Prever SB, Brusca A. Interventional cardiology in pregnancy. Eur Heart J 1996;17:182–8.

13. Pomini F, Mercogliano D, Cavalletti C et al. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg 2000;61:259–68.

14. Vajifdar BU, Gupta AK, Kerkar PG et al. Pre-natal echo-cardiographic diagnosis and neonatal balloon dilatation of severe valvar pulmonic stenosis. Indian J Pediatr 1999;66:799–803.

15. Burn J, Brennan P, Little J et al. Recurrence risks in offspring of adults with major heart defects. Results from first cohort of British collaborative study. Lancet 1998; 351:311–6.

16. Deal K. Woolley coarctation of the aorta and pregnancy. Ann Intern Med 1973;78:706–10.

17. Genoni M, Jenni R, Hoerstrup SP et al. Pregnancy after atrial repair for transposition of the great arteries. Heart 1999; 81:276–7.

18. Connnolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of the great arteries. J Am Coll Cardiol 1999;84:820–4.

19. Canobbio M, Mair D, van der Velde M et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28:763–7.

20. Tan HL, Lie KI. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 2001;22:458–64.

21. Bloomfield TH, Hawkins DF. The effect of drugs on the human fetus. In: Setchell, Ginsberg, editors. Scientific foundations of obstetrics and gynaecology. Oxford: Butterworth Heinemann; 1991, p. 320–36.

22. Magee LA, Downar E, Sevner M et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995;172:1307–11.

23. James C, Banner T, Caton D. Cardiac output in women undergoing caesarean section with epidural or general anesthesia. Am J Obstet Gynecol 1989;160:1178–82.

24. De Paepe A, Devereux R, Dietz H et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62:417–26.

25. Child AH. Marfan syndrome — current medical and genetic knowledge: how to treat and when. J Card Surg 1997;12(Suppl):131–6.

26. Child AH. Pregnancy management in Marfan syndrome and other connective tissue disorders. In: Oakley C, editor. Management of pregnancy in women with cardiac disease. London: BMA publications; 1997, p. 153–62.

27. Pyeritz R. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 1981;71:784–90.

28. Rossiter J, Repke JT, Morales AJ et al. A prospective longitudinal evaluation of pregnancy in women with Marfan syndrome. Am J Obstet Gynecol 1995; 183:1599–606.

29. Lipscomb KJ, Smith JC, Clarke B et al. Outcome of pregnancy in women with Marfan syndrome. Br J Obstet Gynaecol 1997;104: 201–6.

30. Erbel R, Alfonso F, Boileau C et al. Task force report: diagnosis and management of aortic dissection. Eur Heart J 2001;22:1642–81.

31. Gott VL, Pyeritz RE, Magovern GJ Jr. et al. Surgical treatment of aneurysms of the ascending aorta in the Marfan syndrome: results of composite-graft repair in 50 patients. N Engl J Med 1986;314: 1070–4.

32. Yacoub MH, Gehle P, Chandrasekaran V et al. Late results of a valvepreserving operation in patients with aneurysms of the ascending aorta and root. J Thorac Cardiovasc Surg 1998;115(5):1080–90.

33. Pinosky ML, Hopkins RA, Pinckert TL et al. Anaesthesia for simultaneous cesarean section and acute aortic dissection repair in a patient with Marfan syndrome. J Cardiothorac Vasc Anesth 1994;8:451–4.

34. Pyeritz R, Fishman EK, Bernhardt BA et al. Dural ectasia is a common feature of Marfan syndrome. Am J Hum Genet 1988;43(5): 726–32.

35. Steinmann B, Royce PM, Superti-Furga A. The Ehlers–Danlos syndrome. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley; 1993, p. 351–457.

36. Pope FM, Narcisi P, Nicholls AC et al. COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol 1996;135:163–81.

37. Coady M, Davies R, Roberts M et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999;134:361–7.

38. Furthmayr H, Francke U. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights. Semin Thorac Cardiovasc Surg 1997; 9:191–205.

39. Iserin L, Jondeau G, Sidi D et al. Manifestations cardiovasculaires et indications therapeutiques. Arch Mal Coeur Vaiss 1997;90(Suppl): 1701–5.

40. Chia YT, Yeoh SC, Lim MC et al. Pregnancy outcome and mitral valve prolapse. Asia Oceania J Obstet Gynaecol 1994; 20:383–8.

41. Hagay ZJ, Weissman A, Geva D et al. Labor and delivery complicated by acute mitral regurgitation due to ruptured chordae tendineae. Am J Perinatol 1995;12:111–2.

42. Sheikh F, Rangwala S, DeSimone C et al. Management of the parturient with severe aortic incompetence. J Cardiothorac Vasc Anesth 1995;9:575–7.

43. Khandelwal M, Rasanen J, Ludormirski A et al. Evaluation of fetal and uterine hemodynamics during maternal cardiopulmonary bypass. Obstet Gynecol 996;88:667–71.

44. Hameed A, Karaalp IS, Tummala PP et al. The effect of valvular heart disease on maternal and fetal outcome during pregnancy. J Am Coll Cardiol 2001;37:893–9. 45. Bryg RJ, Gordon PR, Kudesia VS et al. Effect of pregnancy on pressure gradient in mitral stenosis. Am J Cardiol 1989; 63:384–6.

45. Avila WS, Grinberg M, Decourt LV et al. Clinical course of women with mitral valve stenosis during pregnancy and puerperium. Arq Bras Cardiol 1992;58:359–64.

46. Al Kasab SM, Sabag T, Al Zaibag M et al. Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol 1990;163:37–40.

47. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J 1990;301:587–9.

48. Clark SL, Phelan JP, Greenspoon J et al. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol 1985;152:984–8.

49. Jakobi P, Adler Z, Zimmer EZ et al. Effect of uterine contractions on left atrial pressure in a pregnant woman with mitral stenosis. Br Med J 1989;298:27.

50. Ducey JP, Ellsworth SM. The hemodynamic effects of severe mitral stenosis and pulmonary hypertension during labor and delivery. Intensive Care Med 1989;15:192–5.

51. Zitnik RS, Brandenburg RO, Sheldon R et al. Pregnancy and openheart surgery. Circulation 1969;39(Suppl 1):257–62.

52. Bernal JM, Miralles PJ. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obstet Gynecol Surv 1986;41:1–6.

53. Sullivan HJ. Valvular heart surgery during pregnancy. Surg Clin North Am 1995;75:59–75.

54. Rossouw GJ, Knott-Craig CJ, Barnard PM et al. Intracardiac operation in seven pregnant women. Ann Thorac Surg 1993; 55:1172–4.

55. Weiss BM, von Segesser LK, Alon E et al. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 1998;179:1643–53.

56. Levy DL, Warriner RA, Burgess GE. Fetal response to cardiopulmonary bypass. Obstet Gynecol 1980;56:112–5.

57. Lamb MP, Ross K, Johnstone AM et al. Fetal heart monitoring during open heart surgery. Two case reports. Br J Obstet Gynecol 1981; 88:669-74.

58. El Maraghy M, Abou Senna I, El-Tehewy F et al. Mitral valvotomy in pregnancy. Am J Obstet Gynecol 1983; 145:708–10.

59. Vosloo S, Reichart B. The feasability of closed mitral valvotomy in pregnancy. J Thorac Cardiovasc Surg 1987; 93:675–9.

60. Pavankumar P, Venugopal P, Kaul U et al. Closed mitral valvotomy during pregnancy. A 20-year experience. Scand J Thor Cardiovasc Surg 1988;22:11–5.

61. Esteves CA, Ramos AIO, Braga SLN et al. Effectiveness of percutaneous balloon mitral valvotomy during pregnancy. Am J Cardiol 1991;68:930–4.

62. Patel JJ, Mitha AS, Hassen F et al. Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis. Am Heart J 1993;125:1106–9.

63. Iung B, Cormier B, Elias J et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994;73:398–400.

64. Kalra GS, Arora R, Khan JA et al. Percutaneous mitral commissurotomy for severe mitral stenosis during pregnancy. Cathet Cardiovasc Diagn 1994;33:28–30.

65. Gupta A, Lokhandwala Y, Satoskar P et al. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes. JAm Coll Surg 1998;187:409–15.

66. Ben Farhat M, Gamra H, Betbout F et al. Percutaneous balloon mitral commissurotomy during pregnancy. Heart 1997;77:564–7.

67. Mangione JA, Lourenco RM, dos Santos ES et al. Long-term followup of pregnant women after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv 2000;50:413–7.

68. De Souza JAM, Martinez EE, Ambrose JA et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy during pregnancy. J Am Coll Cardiol 2001;37: 900–3.

69. Patel JJ, Munclinger MJ, Mitha AS et al. Percutaneous bal-loon dilatation of the mitral valve in critically ill young patients with intractable heart failure. Br Heart J 1995; 73:555–8.

70. Lao TT, Sermer M, MaGee L et al. Congenital aortic stenosis and pregnancy—a reappraisal. Am J Obstet Gynecol 1993;169:540–5.

71. McIvor RA. Percutaneous balloon aortic valvuloplasty during pregnancy. Int J Cardiol 1991;32:1–3.

72. Lao TT, Adelman AG, Sermer M et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol 1993;100:1141–2.

73. Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J 1993;70:544–5.

74. Ben-Ami M, Battino S, Rosenfeld T et al. Aortic valve replacement during pregnancy. A case report and review of the literature. Acta Obstet Gynecol Scand 1990;69:651–3.

75. De Boer K, Ten Cate JW, Sturk A et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95–100.

76. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191–6.

77. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196–201.

78. Sareli P, England MJ, Berk MR et al. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 1989;63:1462–5.

79. Gohlke-Barwolf C, Acar J, Oakley C et al. Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on valvular heart disease of the European Society of Cardiology. Eur Heart J 1995;16:1320–30.

80. Prendergast B, Banning AP, Hall RJC. Valvular heart disease: recommendations for investigation and management. Summary of guidelines produced by a working group of the British Cardiac Society and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond 1996;30:309–15.

81. Bonow RO, Carabello B, De Leon AC et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 1998;32: 1486–588.

82. Oakley CM. Pregnancy and prosthetic heart valves. Lancet 1994;344:1643–4.

83. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol 1996;27:1704–6.

84. Hanania G. Management of anticoagulants during pregnancy. Heart 2001;86:125–6.

85. Vitale N, De Feo M, De Santo LS et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637–41.

86. Salazar E, Izaguirre R, Verdejo J et al. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698–703.

87. Hanania G, Thomas D, Michel PL et al. Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 1994;15:1651–8.

88. Menschengieser SS, Fondevila CG, Santarelli MT et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23–6.

89. Sadler L, McCowan L, White H et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Obstet Gynaecol 2000;107:245–53.

90. Montalescot G, Polle V, Collet JP et al. Low molecular weight heparin after mechanical heart valve replacement.Circulation 2000;101: 1083–6.

91. Sanson BJ, Lensing AWA, Prins MH et al. Safety of lowmolecularweight heparin in pregnancy: a systematic review. Thromb Haemost 1999;81:668–72.

92. Lee LH. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996;76:628–9.

93. Tenconi PM, Gatti L, Acaia B. Low molecular weight heparin in a pregnant woman with mechanical heart valve prosthesis: a case report. Thromb Haemost 1997;79:733.

94. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S–31S.

95. North RA, Sadler L, Stewart AW et al. Long-term survival and valverelated complications in young women with cardiac valve replacements. Circulation 1999;99:2669–76.

96. Piehler JM, Blackstone EH, Bailey KR et al. Reoperation on prosthetic heart values. Patient-specific estimates of inhospital events. J Thorac Cardiovasc Surg 1995;109:30–48.

97. Kee WD, Shen J, Chiu AT et al. Combined spinal-epidural analgesia in the management of labouring parturients with mitral stenosis. Anaesth Intensive Care 1999;27:523–6.

98. Brian JE Jr., Seifen AB, Clark RB. Aortic stenosis, cesarean delivery, and epidural anesthesia. J Clin Anesth 1993;5:154–7.

99. McKenna R, Cole ER, Vasan V. Is warfarin sodium contraindicated in the lactating mother? J Pediatr 1983;103:325–7. 101. Bac DJ, Lotgering FK, Verkaaaik APK et al. Spontaneous coronary artery dissection during pregnancy and postpartum. Eur Heart J 1995;16:136–8.

100. Rallings P, Exner T, Abraham R. Coronary artery vasculitis and myocardial infarction associated with antiphospholipid antibodies in a pregnant woman. Aust NZ J Med 1989;19:347–50.

101. Parry G, Goudevenos J-C, Williams DO. Coronary thrombosis postpartum in a young woman with Still's disease. Clin Cardiol 1992;15:305–7.

102. Pearson GD, Veille J-C. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.

103. Van Hoeven KH, Kitsis RN, Katz SD et al. Peripartum versus idiopathic dilated cardiomyopathy in young women-a comparison of clinical, pathological and prognostic features. Int J Cardiol 1993;40:57–65.

104. Elkayam U, Tummala PP, Rao K et al. Maternal and fetal outcome of subsequent pregnancies in women with peripartum cardiomyopathy. New Engl J Med 2001;344:1567–71.

105. De Souza JL Jr., de Carvalho Frimm C, Nastari L et al. Left ventricular function after a new pregnancy in patients with peripartum cardiomyopathy. J Card Fail 2001;7:36–7.

106. Bozkurt B, Villaneuva FS, Holubkov R et al. Intravenous Immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999;34:177–80.

107. Purcell IF, Williams DO. Peripartum cardiomyopathy complicating severe aortic stenosis. Int J Cardiol 1995;52:163–6.

108. Oakley CM, Nihoyannopoulos P. Peripartum cardiomyopathy with recovery in a patient with coincidental Eisenmenger ventricular septal defect. Br Heart J 1992;67:190–2.

109. Oakley CM. Hypertrophic cardiomyopathy in heart disease in pregnancy. New York: BMJ Publishing, 1997, p. 201–209.

110. Kazimuddin M, Vashist A, Basher AW et al. Pregnancy induced severe left ventricular systolic dysfunction in a patient with hypertrophic cardiomyopathy. Clin Cardiol 1998;21:848–50.

111. Redhead, Fadell EJ. Bacteraemia during parturition. JAMA 1959;160:1284–5.

112. Baker TH, Hubbell R. Reappraisal of asymptomatic puerperal bacteraemia. Am J Obstet Gynecol 1967;97:575–6.

113. Sugrue D, Blake S, Troy P. Antibiotic prophylaxis against infective endocarditis after normal delivery - is it necessary? Br Heart J 1980;44:499–522.

114. Joglar JA, Page RI. Treatment of cardiac arrhythmias during pregnancy; safety considerations. Drug Saf 1999;20:85–94.

115. Natale A, Davidson T, Geiger MJ. Implantable cardioverter defibrillators and pregnancy. A safe combination? Circulation 1997;96: 2808–12.

116. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.

117. Higgins JR, de Swiet M. Blood pressure measurement and classification in pregnancy. Lancet 2001;357:131–5.

118. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260–5.

119. Barton JR, O’Brien JM, Bergauer NK et al. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001;184:979–83.

120. Sibai BM, Mabie WC, Shamsa F et al. A comparison of no medication versus methyl dopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990;162:960–5.

121. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257–65.

122. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318:1332–6.

123. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001;357:53–6.

124. Cockburn J, Moar VA, Ounsted M et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647–9.

125. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio ipertensione in Gravidanza. Br J Obstet Gynaecol 1998;105:718–22.

126. Magee LA, Schick B, Donnenfeld AE et al. The safety of calcium channel blockers in human pregnancy: a prospective multicenter cohort study. Am J Obstet Gynecol 1996;174:823–8.

127. Horvath JS, Phippard A, Korda A et al. Clonidine hydrochloride—a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985;66:634–8.

128. Lain Y, Roberts JM. Contemporary concepts of the pathogenesis and management of pre-eclampsia. JAMA 2002;287:3183–6.

129. Hanssens M, Keirse MJ, Vankelecom F et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128–35.

130. Heyborne KD. Pre-eclampsia prevention: lessons from the low dose aspirin therapy trials. Am J Obstet Gynecol 2000;183:523–8.

131. Duley L, Henderson-Smart DE, Knight M et al. Anti-platelet drugs for prevention of pre-eclampsia and its consequences: a systematic review. BMJ 2001;322:329–33.

132. Chambers JC, Fusi L, Malik IS et al. Association of maternal endothelial dysfunction with pre-eclampsia. JAMA 2001;285: 1607–12.


For citation:


. EXPERT CONSENSUS DOCUMENT ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY. Rational Pharmacotherapy in Cardiology. 2006;2(1):73-92. (In Russ.)

Views: 239


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)